Literature DB >> 27660028

Angiotensin-(1-5), an active mediator of renin-angiotensin system, stimulates ANP secretion via Mas receptor.

Lamei Yu1, Kuichang Yuan2, Hoang Thi Ai Phuong1, Byung Mun Park1, Suhn Hee Kim3.   

Abstract

Angiotensin-(1-5) [Ang-(1-5)], which is a metabolite of Angiotensin-(1-7) [Ang-(1-7)] catalyzed by angiotensin-converting enzyme (ACE), is a pentapeptide of the renin-angiotensin system (RAS). It has been reported that Ang-(1-7) and Ang-(1-9) stimulate the secretion of atrial natriuretic peptide (ANP) via Mas receptor (Mas R) and Ang II type 2 receptor (AT2R), respectively. However, it still remains unknown whether Ang-(1-5) has a similar function to Ang-(1-7). We investigated the effect of Ang-(1-5) on ANP secretion and to define its signaling pathway using isolated perfused beating rat atria. Ang-(1-5) (0.3, 3, 10μM) stimulated high pacing frequency-induced ANP secretion in a dose-dependent manner. Ang-(1-5)-induced ANP secretion (3μM) was attenuated by the pretreatment with an antagonist of Mas R (A-779) but not by an antagonist of AT1R (losartan) or AT2R (PD123,319). An inhibitor for phosphatidylinositol 3-kinase (PI3K; wortmannin), protein kinase B (Akt; API-2), or nitric oxide synthase (NOS; L-NAME) also attenuated the augmentation of ANP secretion induced by Ang-(1-5). Ang-(1-5)-induced ANP secretion was markedly attenuated in isoproterenol-treated hypertrophied atria. The secretagogue effect of Ang-(1-5) on ANP secretion was similar to those induced by Ang-(1-9) and Ang-(1-7). These results suggest that Ang-(1-5) is an active mediator of renin-angiotensin system to stimulate ANP secretion via Mas R and PI3K-Akt-NOS pathway. Copyright Â
© 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Angiotensin-(1-5); Angiotensin-(1-7); Atrial natriuretic peptide; Hypertrophy; Isoproterenol; Receptor

Mesh:

Substances:

Year:  2016        PMID: 27660028     DOI: 10.1016/j.peptides.2016.09.009

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  22 in total

1.  Molecular remodeling of the renin-angiotensin system after kidney transplantation.

Authors:  Marlies Antlanger; Oliver Domenig; Johannes J Kovarik; Christopher C Kaltenecker; Chantal Kopecky; Marko Poglitsch; Marcus D Säemann
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2017 Apr-Jun       Impact factor: 1.636

2.  ACE2 as Drug Target of COVID-19 Virus Treatment, Simplified Updated Review.

Authors:  Gomaa Mostafa-Hedeab
Journal:  Rep Biochem Mol Biol       Date:  2020-04

Review 3.  SARS-CoV-2, ACE2 expression, and systemic organ invasion.

Authors:  Usman M Ashraf; Ahmed A Abokor; Jonnelle M Edwards; Emily W Waigi; Rachel S Royfman; Syed Abdul-Moiz Hasan; Kathryn B Smedlund; Ana Maria Gregio Hardy; Ritu Chakravarti; Lauren Gerard Koch
Journal:  Physiol Genomics       Date:  2020-12-04       Impact factor: 3.107

4.  Angiotensin II type 1 receptor mediates pulmonary hypertension and right ventricular remodeling induced by inhaled nicotine.

Authors:  Nicholas D Fried; Tamara M Morris; Anna Whitehead; Eric Lazartigues; Xinping Yue; Jason D Gardner
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-02-12       Impact factor: 4.733

5.  Cardiovascular effects of small peptides of the renin angiotensin system.

Authors:  Patrícia L Moraes; Lucas M Kangussu; Luiz Gonzaga da Silva; Carlos H Castro; Robson A S Santos; Anderson J Ferreira
Journal:  Physiol Rep       Date:  2017-11

6.  Comparative effects of angiotensin II and angiotensin-(4-8) on blood pressure and ANP secretion in rats.

Authors:  Hoang Thi Ai Phuong; Lamei Yu; Byung Mun Park; Suhn Hee Kim
Journal:  Korean J Physiol Pharmacol       Date:  2017-10-30       Impact factor: 2.016

7.  Recombinant human ACE2: acing out angiotensin II in ARDS therapy.

Authors:  Haibo Zhang; Andrew Baker
Journal:  Crit Care       Date:  2017-12-13       Impact factor: 9.097

8.  Plasma and tissue angiotensin-converting enzyme 2 activity and plasma equilibrium concentrations of angiotensin peptides in dogs with heart disease.

Authors:  Éva Larouche-Lebel; Kerry A Loughran; Mark A Oyama; Phil F Solter; Danielle S Laughlin; Melissa D Sánchez; Charles-Antoine Assenmacher; Philip R Fox; Ryan C Fries
Journal:  J Vet Intern Med       Date:  2019-06-28       Impact factor: 3.333

Review 9.  Novel Therapeutic Approaches Targeting the Renin-Angiotensin System and Associated Peptides in Hypertension and Heart Failure.

Authors:  Lauren B Arendse; A H Jan Danser; Marko Poglitsch; Rhian M Touyz; John C Burnett; Catherine Llorens-Cortes; Mario R Ehlers; Edward D Sturrock
Journal:  Pharmacol Rev       Date:  2019-10       Impact factor: 25.468

10.  Effect of Melatonin on the Renin-Angiotensin-Aldosterone System in l-NAME-Induced Hypertension.

Authors:  Fedor Simko; Tomas Baka; Kristina Krajcirovicova; Kristina Repova; Silvia Aziriova; Stefan Zorad; Marko Poglitsch; Michaela Adamcova; Russel J Reiter; Ludovit Paulis
Journal:  Molecules       Date:  2018-01-29       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.